Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05914441 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Spanish-Portuguese Thrombotic Thrombocytopenic Purpura Registry

Study acronym: RE-PTT
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 29, 2024 (before its estimated September 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study sites: 6 to 7v7
  2. Study sites: 5 to 6v6
  3. Study sites: 4 to 5v5
  4. Study sites: 3 to 4v4
  5. Study sites: 1 to 3v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 2023 to Mar 22, 2024
    • Site details revised
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
REPTT is an observational, prospective, multi-country, multicentre and non-interventional registry in which at least 300 patients with Thrombotic thrombocytopenic purpura (TTP) in Spain and Portugal will be evaluated. The study will be carried out in the context of the usual clinical practice conditions, not imposing restrictions on the participating physician or influencing their normal clinical practice.
Trial Details
NCT Number NCT05914441
Lead Sponsor Fundación Española de Hematología y Hemoterapía
Conditions
(from sponsor)		 Purpura, Thrombocytopenic
Related terms Purpura, Thrombocytopenic, Purpura, Thrombotic Thrombocytopenic
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov